NRX Pharmaceuticals, Inc. (NRXP) Q4 2024 Annual Earnings — Miss Estimates

Screener

Reported March 14, 2025 · Before market open

Revenue$4.0KMiss by $5.0M

EPS-$0.30Miss by $0.10

Revenue estimate$5.0M

EPS estimate-$0.20

Next report

Nov 13, 2026 (in 2 months)

Revenue estimate$1.3M

EPS estimate-$0.26

Versus estimates

Revenue

Q2 2026$1.1MMiss by $228.7K Q1 2026$1.1MMiss by $18.4M Q4 2025$983.0KMiss by $6.5M Q3 2025$242.0KMiss by $7.3M Q1 2025$2.3M

Q4 2024$4.0KMiss by $5.0M

Diluted EPS

Q2 2026-$0.44Miss by $0.33 Q1 2026-$0.04Beat by $0.01 Q4 2025$0.19Beat by $0.28 Q3 2025-$0.18Miss by $0.07 Q1 2025-$0.34Miss by $0.04

Q4 2024-$0.30Miss by $0.10

FAQ

When did NRX Pharmaceuticals, Inc. report Q4 2024 earnings?: NRX Pharmaceuticals, Inc. (NRXP) reported Q4 2024 earnings on March 14, 2025 before market open.
What were NRX Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?: NRX Pharmaceuticals, Inc. reported revenue of $4.0K and eps of $-0.30 for Q4 2024.
Did NRX Pharmaceuticals, Inc. beat estimates in Q4 2024?: Revenue missed the consensus estimate of $5.0M by $5.0M. EPS missed the consensus estimate of $-0.20 by $0.10.
Where can I find NRX Pharmaceuticals, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001437749-25-007743) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment NRX Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk